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Introduction {#sec001}
============

Parasitic organisms frequently use multiple hosts and have several morphologically and transcriptionally distinctive life cycle stages. Within each host, parasites must circumvent immune defenses and navigate to new tissues. There are frequently extreme bottlenecks in parasite numbers during transmission \[[@pgen.1008453.ref001]\], with rapid proliferative growth within hosts, and intense competition between co-infecting parasite genotypes. For example, the life cycle of malaria parasites involves successive infection of two hosts: female *Anopheles* mosquitoes, where gamete fusion, meiosis and recombination occurs, and humans in which parasites travel from the skin, develop in the liver and then proliferate asexually in the blood stream. Ideally, we would like to understand how natural selection operates across the complete life cycle and document the genes subject to selection pressures at each life cycle stage: during erythrocytic growth, gametocyte production, oocyst development in the mosquito midgut, migration of sporozoites to the salivary glands, transmission from the salivary glands, sporozoite survival in the skin, and establishment and parasite growth during liver stage development and exoerythrocytic merozoite release.

Selection can be directly measured by examining changes in allele frequency across these developmental stages. Shifts in allele frequencies in populations of thousands of progeny generated by experimental genetic crosses provide locus-specific readouts of competitive fitness. For example, deep sequencing of bulk populations containing thousands of recombinants identified genes selected under different regimens in yeast and *Caenorhabditis elegans* \[[@pgen.1008453.ref002]--[@pgen.1008453.ref005]\]. Bulk segregant analysis (BSA) has also been successfully applied to studies of several different parasitic organisms including coccidia (*Eimeria tenella*) and the human blood fluke *Schistosoma mansoni* \[[@pgen.1008453.ref006], [@pgen.1008453.ref007]\]. Our work was inspired by an exciting series of papers applying pooled sequencing approaches (termed linkage group selection in the malaria literature) for mapping genes of interest in rodent malaria parasites \[[@pgen.1008453.ref008]--[@pgen.1008453.ref013]\].

Most studies of *Plasmodium falciparum* to date focus only on the asexual erythrocytic stages \[[@pgen.1008453.ref008], [@pgen.1008453.ref014]--[@pgen.1008453.ref017]\], because they can be easily cultured *in vitro* in red blood cells, circumventing the need for humans or great apes, the natural hosts for this parasite. Two new research tools now allow us to examine selection across the complete life cycle of *P*. *falciparum*. First, we can maintain the complete life cycle of *P*. *falciparum* in a laboratory setting by using humanized mice \[[@pgen.1008453.ref018]\] in place of splenectomized chimpanzees or human volunteers. These mice contain human hepatocytes and are therefore able to support liver stage development of *P*. *falciparum*. Hence, we can stage genetic crosses between different *P*. *falciparum* parasites, including parasites recently isolated from infected patients, and sample multiple parasite life cycle stages for measurement of allele frequency changes throughout the life cycle. Second, selective whole genome amplification (sWGA) provides a simple and effective way to enrich *Plasmodium* DNA from contaminating host tissues. This is critical because *Plasmodium* DNA constitutes a very small fraction of DNA present in malaria-infected mosquitoes; likewise, *Plasmodium* DNA makes up a very small fraction of DNA extracted from malaria-infected livers (**[Table 1](#pgen.1008453.t001){ref-type="table"}**). sWGA uses short 8--12 mer oligonucleotide probes that preferentially bind to the target genome, rather than random hexamers used in normal whole genome amplification. This approach was pioneered by Leichty and Brisson \[[@pgen.1008453.ref019]\], and protocols for sWGA have been successfully developed to amplify and sequence malaria parasite genomes from contaminating host tissues \[[@pgen.1008453.ref020]--[@pgen.1008453.ref023]\].
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###### Sample collection and sequence statistics.

![](pgen.1008453.t001){#pgen.1008453.t001g}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parasite stage                                                                   \(1\) Early\   \(2\) Maturing\      \(3\) Sporozoite      \(4\) Liver\         \(5\) *In vivo*\                 \(6\) *In vitro*\
                                                                                   Oocyst         oocyst                                     Stage                Blood                            Blood
  -------------------------------------------------------------------------------- -------------- -------------------- --------------------- -------------------- -------------------------------- ---------------------------------
  Collecting time[^a^](#t001fn001){ref-type="table-fn"}                            d4             d10                  d14                   d21                  d21                              d22-52

  Sample collected                                                                 48 midguts     48 midguts           200 Salivary glands   60 mg liver          50ul blood (3.5% parasitaemia)   50ul blood (1--4% parasitaemia)

  Total DNA (ng)                                                                   1,397          1,337                3,675                 9,359                142                              154--2,576

  Total *P*. *falciparum* genome copies[^b^](#t001fn002){ref-type="table-fn"}      7,563          866,299              4,726,149             12,521,577           1,246,535                        19.1M-279.6M

  *P*. *falciparum* DNA percent before sWGA                                        0.01%          2%                   3%                    3%                   30%                              100%

  Sequencing approach[^c^](#t001fn003){ref-type="table-fn"}                        Amplicon       Amplicon, sWGA-WGS   Amplicon, sWGA-WGS    Amplicon, sWGA-WGS   Amplicon, sWGA-WGS, WGS          Amplicon, sWGA-WGS, WGS

  Copies of *P*. *falciparum* genome for sWGA                                      na             2×10^5^              2×10^5^               2×10^5^              2×10^5^                          2×10^5^

  *P*. *falciparum* DNA percent after sWGA[^d^](#t001fn004){ref-type="table-fn"}   na             88.09%               86.74%                97.16%               95.31%                           97.33%-99.57%
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

a, Parasite stages and sample collecting times are as shown in [Fig 1](#pgen.1008453.g001){ref-type="fig"}. Day 0 was defined as the day mosquitoes took a blood meal with gametocytes from two parents.

b, We qualified the parasite genome copy number in the total DNA using qPCR, and translated this into parasite DNA percentage, using 2.48×10^−5^ ng as the weight of the *Plasmodium* genome.

c, For samples with host contamination or small amounts of DNA isolated, we performed selective whole genome amplification (sWGA) before whole-genome sequencing (WGS). We used amplicon sequencing to trace biases in mitochondrial DNA (mtDNA) transmission in those samples. For *in vitro* blood samples, we performed sequencing both before and after sWGA to evaluate the accuracy of allele frequency estimated after sWGA. To obtain sufficient representation of the bulk segregant samples, we used 2×10^5^ copies of parasite genome as template for each sWGA reaction and 1,000 copies for amplicon sequencing.

d, *P*. *falciparum* DNA percentage after sWGA was measured as the percent of reads that mapped to the *P*. *falciparum* 3D7 genome.

Artemisinin resistance is currently spreading across Southeast Asia \[[@pgen.1008453.ref024]\]. SNPs in the *kelch13* (PF3D7_1343700) locus on chromosome (chr) 13 underlie resistance and greater than 124 independent alleles have been recorded in a dramatic example of a soft select sweep \[[@pgen.1008453.ref025], [@pgen.1008453.ref026]\]. One particular allele (*kelch13*-C580Y) is currently replacing other resistant alleles and spreading toward fixation in independent transmission foci in western Cambodia/Laos/Vietnam and the Thailand-Myanmar border \[[@pgen.1008453.ref027]--[@pgen.1008453.ref029]\]. Several studies have suggested that mutations within loci other than *kelch13* may provide a permissive background for evolution of artemisinin resistance or play a compensatory role \[[@pgen.1008453.ref030], [@pgen.1008453.ref031]\], but the role of such accessory loci is poorly understood.

In this study, we measured skews in allele frequencies across the genome in the progeny of a genetic cross between artemisinin resistant (ART-R, *kelch13-*C580Y) and ART sensitive (ART-S, *kelch13*-WT) parasites throughout the life cycle to identify genes that influence parasite fitness in parasite stages infecting both the mosquito and vertebrate host. We used ART-R and ART-S parental parasites in order to examine loci contributing to fitness and compensation for deleterious effects of ART-R alleles \[[@pgen.1008453.ref016]\]. We used the humanized mouse model to allow parasite liver stage development of the genetic cross progeny, sWGA to enrich parasite DNA from host contamination and pooled sequencing to determine temporal changes in allele frequency and characterize genomic regions under selection. Our results demonstrate pervasive selection across the parasite genome over the course of a single parasite generation, selection against progeny produced from selfed matings, and strong locus-specific selection against parasite loci on chr 12 and 14.

Results {#sec002}
=======

Identification of high-confidence SNPs between parents {#sec003}
------------------------------------------------------

*P*. *falciparum* NHP1337 and MKK2835 were cloned by limiting dilution and used as parents for genetic crosses. Both parasites are from the Thailand-Myanmar border. MKK2835 (ART-S) is a *kelch13* wild-type ART-susceptible parasite collected from a patient who visited the clinic in 2003 prior to the spread of ART resistance \[[@pgen.1008453.ref032]\]. NHP1337 is a recent cloned ART-R parasite, that cleared slowly (Clearance half-life (T~½~P) = 7.84 h) from the blood of a patient treated with artemisinin combination therapy in 2011 and carries the C580Y *kelch13* mutant. Parasites with the C580Y mutation have been rapidly spreading in Southeast Asia and are replacing other ART-resistant *kelch13* alleles \[[@pgen.1008453.ref025], [@pgen.1008453.ref033]\]. We detected 9,462 high confidence SNPs-- 1 SNP per 2.43kb--between the two parental strains from the 21 Mb core genome (defined in \[[@pgen.1008453.ref034]\]) (**[S1 Fig](#pgen.1008453.s001){ref-type="supplementary-material"}**). Comparisons with single clone Southeast Asian parasites from the Sanger pf3k project (<ftp://ngs.sanger.ac.uk/production/pf3k/release_5/>), shows that the parental parasites both fall into the group designated as KH1 \[[@pgen.1008453.ref035]\] (**[S7 Fig](#pgen.1008453.s007){ref-type="supplementary-material"}**).

Genetic cross and generation of segregant pools {#sec004}
-----------------------------------------------

To generate segregant pools of progeny, we crossed NHP1337 and MKK2835 (**[Fig 1](#pgen.1008453.g001){ref-type="fig"}**). We fed 500 mosquitoes with a \~50:50 gametocyte mixture of the two parental parasites. Recombinant progeny are generated after gametes fuse to form a diploid zygote that then rapidly transforms into a short-lived tetraploid ookinete which migrates to the basal lamina of the mosquito midgut and transforms into an oocyst. Mitotic division of the 4 meiotic products ultimately leads to the generation of approximately 3000 haploid sporozoites within each oocyst \[[@pgen.1008453.ref036]\]. Oocyst prevalence was 80% with an average burden of three oocysts per mosquito midgut (range: 0--6), giving an estimate of 12 (3×4) recombinant genotypes per mosquito. We dissected a proportion of the infected mosquitoes to collect midguts (48 at each time point) for monitoring allele frequencies during oocyst development. Salivary gland sporozoites from 204 mosquitoes were pooled together and injected in to a single FRG huHep mouse.

![Genetic mapping of parasite competition throughout the *Plasmodium falciparum* life cycle.\
We generated genetic crosses using *Anopheles stephensi* mosquitoes and FRG huHep mice. We collected midgut and salivary glands from infected mosquitoes, infected mouse liver and emerging merozoites from *in vivo* blood, and recovered aliquots of *in vitro* cultured progeny parasites at intervals of 30 days (marked with arrows, parasite stages 1--6). Cross generation and sample collection were completed in two months (marked in green). For samples with host contamination or small amounts of DNA isolated (blue arrows, [Table 1](#pgen.1008453.t001){ref-type="table"}), selective whole genome amplification (sWGA) was performed before Illumina whole-genome sequencing (WGA). We used amplicon sequencing to trace biases in mtDNA transmission in those samples. For *in vitro* blood samples (pink arrow), we performed sequencing both before and after sWGA to evaluate the accuracy of allele frequency after sWGA.](pgen.1008453.g001){#pgen.1008453.g001}

We collected samples for allele frequency analysis from infected mosquito midguts, infected mosquito salivary glands, infected humanized mouse livers and infected blood (both mouse blood and injected human red blood cells) after the liver stage-to-blood stage transition. We then recovered aliquots of *in vitro* cultured progeny parasites at two-four day intervals over 30 days (**[Fig 1](#pgen.1008453.g001){ref-type="fig"}**). We also set up cultures to enrich gametocytes from the *in vitro* cultures. These samples represent the important developmental stages across the parasite life cycle, including early oocyst, maturing oocyst, sporozoites, liver stage schizonts, transitioned blood stage parasites, fifteen asexual cycles in blood stage culture and reproductive gametocytes, required for transmission to the mosquito (**[Table 1](#pgen.1008453.t001){ref-type="table"}**). Our experiment examines the impact of selection across one complete *P*. *falciparum* life cycle.

We measured the total number of parasite genome copies and the amount of host DNA contamination for these segregant pools using qPCR. At the early midgut oocyst stage (4 days after mosquito infection), we isolated \~8,000 copies of the *P*. *falciparum* genome from 48 mosquito midguts. The parasite DNA represented approximately 0.01% of the total DNA within these isolated midguts. The percentage reached 1.80% after 10 days of mosquito infection, indicating a 196-fold increase of parasite DNA in the six days following initial midgut isolation. The percentage of parasite DNA found in samples from mosquito salivary gland containing sporozoites, liver containing liver stage parasites and liver stage-to-blood stage transitioned *in vivo* blood samples were 3%, 3% and 30%, respectively (**[Table 1](#pgen.1008453.t001){ref-type="table"}**).

sWGA-WGS, WGS and amplicon sequencing {#sec005}
-------------------------------------

We used three approaches to sequence the segregant pools and quantify allele frequencies: (1) selective whole genome amplification combined with whole genome sequencing (sWGA-WGS), (2) direct whole genome sequencing (WGS) and (3) amplicon sequencing. The methods used were dependent on the level of host contamination and the total amount of DNA present in the samples (**[Table 1](#pgen.1008453.t001){ref-type="table"}**). We used multiple methods where possible to determine potential bias. We used the sWGA approach to enrich parasite DNA before WGS in samples with extensive host contamination, including the mosquito and the FRG NOD human-chimeric mouse liver (**[Table 1](#pgen.1008453.t001){ref-type="table"}, sample 2--5**). With 0.2×10^6^ copies of parasite genome as template, the sWGA-WGS approach yielded 0.6--1.4 μg of product after 3h of amplification, of which \> 88% was from *P*. *falciparum*, for both mosquito and mouse samples. By sequencing pools to \~100× coverage, comparable results were obtained between samples prepared by the sWGA-WGS approach and the WGS approach (**[Fig 2A](#pgen.1008453.g002){ref-type="fig"}, [Fig 3](#pgen.1008453.g003){ref-type="fig"} and [Fig 4](#pgen.1008453.g004){ref-type="fig"}**). We used amplicon sequencing \[[@pgen.1008453.ref016]\] to determine the frequencies of mtDNA from the two parents in those samples for which we used sWGA (**[Fig 2C](#pgen.1008453.g002){ref-type="fig"} and [S2 Fig](#pgen.1008453.s002){ref-type="supplementary-material"}**). This was necessary because our sWGA primers were specifically designed to minimize amplification of mtDNA, since we were concerned that sWGA with circular DNA would inundate autosomal sWGA products. For day 4 mosquito midgut samples, we only obtained amplicon sequencing data since there was insufficient parasite DNA for a successful sWGA.

![Change in frequency of the mitochondria and core genome at different infection stages.\
(A) Ridgeline plots showed genome-wide allele frequency distributions of NHP1337 throughout the *Plasmodium* life cycle. Each frequency distribution shows the frequency of genome-wide SNPs (9,462) found in progeny bulks at different time points of the parasite life cycle. \* indicates Cohen's *d* effect size \> 0.5, and \*\* indicates effect size \> 0.8. (B) We detected strong concordance between allele frequencies estimated from experimental replicates. (C) The allele frequency estimated from the mitochondria and core genome showed the same pattern of skew across the life cycle. (D) Natural log of the genotype ratio (NHP1337/MKK2835) plotted against asexual life cycles. The selection coefficient was estimated as the slope of the least-squares fit. Allele frequencies from day30 to day42 were used here. There was no significant difference between fitness costs estimated for the core genome and mitochondria (*P* = 0.363). Positive values of *s* indicate a selection disadvantage for NHP1337. MT, mitochondria; *s*, selection coefficients; R, correlation coefficient. X-axis in (A) and (C) indicated sample collecting days and corresponding parasite developmental stages.](pgen.1008453.g002){#pgen.1008453.g002}

![Plot of allele frequencies across the genome throughout the *Plasmodium falciparum* life cycle.\
We divided the parasites into two replicates after two days of *in vitro* culture (day 23). Orange and black indicate allele frequencies from these two parallel cultures. Red and blue lines show tricube-smoothed allele frequencies. Black dashed lines indicate the average allele frequency across the genome. Sample collecting days are marked on the right. Day 10 shows allele frequencies of maturing oocysts, day 14 shows sporozoites, day 21.1 shows liver stage schizonts, day 21.2 shows transitioned blood stage parasites, and day 23--50 shows fifteen asexual cycles in blood stage culture.](pgen.1008453.g003){#pgen.1008453.g003}

![Allele frequencies estimated before and after selective whole genome amplification (sWGA).\
(A) Plot of allele frequencies across the genome. (B) Concordance between allele frequencies estimated before and after sWGA.](pgen.1008453.g004){#pgen.1008453.g004}

Evaluation of bias in allele frequency measurements {#sec006}
---------------------------------------------------

To evaluate the accuracy of allele frequencies estimated after sWGA, we sequenced blood samples using both the sWGA-WGS approach and the WGS approach. We plotted allele frequencies of the parent NHP1337 across the genome and tricube-smoothed the frequency with a window size of 100kb to smooth out noise and estimate changes in adjacent regions. With 10 million 150 bp pair-end sequencing reads, there were fewer loci detected with coverage \> 30× by the sWGA-WGS approach relative to WGS (5,024 loci by sWGA-WGS and 7,844 loci by direct WGS). The allele frequency trends, however, were highly consistent after smoothing (**[Fig 4A](#pgen.1008453.g004){ref-type="fig"}**). The allele frequencies estimated before and after sWGA were strongly concordant (*R*^2^ = 0.985, **[Fig 4B](#pgen.1008453.g004){ref-type="fig"}, [S6 Fig](#pgen.1008453.s006){ref-type="supplementary-material"}**), which strongly supports the comparability of these two different methods.

Allele frequency changes in segregant pools {#sec007}
-------------------------------------------

a.  Mosquito stages: *Plasmodium* sexual blood stage infections differentiate into both male and female gametes and mate; consequently, selfed progeny, resulting from the fusion of gametes from the same parasite genotype, can occur (i.e., NHP1337 male gametes fertilizing NHP1337 female gametes and MKK2835 male gametes fertilizing MKK2835 female gametes). Selection towards selfed progeny is evident from skewing and shifting of whole genome allele frequencies. To investigate population composition at different infection stages, we plotted the allele frequency distribution of *Plasmodium* mitochondria and across the core genome (**[Fig 2](#pgen.1008453.g002){ref-type="fig"}**). We observed a strong skew (\>80%) towards alleles from the ART-R parent in the mosquito stages, which suggests that many selfed progeny from NHP1337 were present.

b.  Liver stage: The allele frequency in the progeny parasite population shifted significantly towards the ART-R parent (NHP1337) at the liver stage. This is evident from comparisons of allele frequency distributions in the liver with those from sporozoites (**[Fig 2A](#pgen.1008453.g002){ref-type="fig"}**, Cohen\'s *d* test, large effect size = 0.89). This skew observed in the liver stage is reduced in merozoites emerging from the liver (Cohen\'s *d* test, medium effect size = 0.61).

c.  Blood stages: During *in vitro* culture, the allele frequency of NHP1337 (ART-R) dropped to 50%, between day 32 and day 40 (Cohen\'s *d* test, effect size = 1.65). We maintained replicate *in vitro* blood cultures from day 23 (corresponds to day 2 of *in vitro* blood stage culture). Highly repeatable skews were observed in allele frequencies across the genome in these two parallel cultures (**[Fig 2A and 2B](#pgen.1008453.g002){ref-type="fig"}**, *R*^2^ = 0.985). Furthermore, we observed the same skews in both the mitochondria and across the core genome (**[Fig 2C](#pgen.1008453.g002){ref-type="fig"}**), strongly suggesting that the selection was against NHP1337 selfed progeny. The NHP1337 selfed progeny were almost eliminated by day 42 and we thus estimated the selection coefficients against the NHP1337 selfed progeny. We observed strong selection against NHP1337 alleles, with *s* = 0.24±0.02 in the core autosomal genome and *s* = 0.22±0.01 in mitochondria (**[Fig 2D](#pgen.1008453.g002){ref-type="fig"}**). There was no significant difference between these two estimates (*p* = 0.363, Least-Squares Means).

d.  Gametocyte generation: The sexual commitment (gametocytogenesis) ratio of *Plasmodium* parasites is considered to be generally low (\< 3%), but variable among different strains and under different conditions \[[@pgen.1008453.ref037]--[@pgen.1008453.ref040]\]. Interestingly, we did not see specific allele frequency changes during the gametocyte enrichment experiment compared to normal *in vitro* blood cultures (**[S3 Fig](#pgen.1008453.s003){ref-type="supplementary-material"}**). These data suggest that progeny from this cross committed to gametocytogenesis at similar rates.

Loci under selection {#sec008}
--------------------

To pinpoint the loci that determine parasite fitness at each life cycle stage, we first plotted the whole genome allele frequencies throughout the life cycle (**[Fig 3](#pgen.1008453.g003){ref-type="fig"}**). In addition to the whole genome skew described above, we also observed specific regions of the genome that showed distortion in allele frequency after day 32. The skews in allele frequencies were remarkably consistent between the two replicate blood stage cultures, suggesting pervasive selection at multiple loci across the genome. We calculated G' values to measure the significance of allelic skews (**[Fig 5A](#pgen.1008453.g005){ref-type="fig"}, [S4 Fig](#pgen.1008453.s012){ref-type="supplementary-material"} and [S1 Table](#pgen.1008453.s009){ref-type="supplementary-material"}**). Two strong quantitative trait loci (QTLs) were identified on chr 12 and 14, with a genome-wide false discovery rate (FDR) \< 0.01. We further used Δ (SNP-index) to determine the direction of the allele frequency changes (**[Fig 5B](#pgen.1008453.g005){ref-type="fig"} and [S4 Fig](#pgen.1008453.s004){ref-type="supplementary-material"}**). In both regions, alleles from NHP1337 (ART-R) were selected against. We then calculated selection coefficients (*s*) across the genome (**[Fig 5C](#pgen.1008453.g005){ref-type="fig"}**). We observed particularly strong selection at these two QTL regions, with *s* = 0.12 on chr12 and *s* = 0.18 on chr14. In addition, there were a set of lower confidence QTLs with lower allele frequency changes and less impact on parasite fitness uncovered across the genome (**[Fig 5](#pgen.1008453.g005){ref-type="fig"} and [S1 Table](#pgen.1008453.s009){ref-type="supplementary-material"}**).

![Bulk segregant analysis.\
(A) QTLs were defined with the G' approach by comparing allele frequencies at each locus to the average allele frequency across the genome. Regions with a FDR \> 0.01 were considered significant QTLs. (B) Δ(SNP-index) for day50 progeny pools. The Δ(SNP-index) is the difference between the SNP-index of each locus and the genome-wide average SNP-index. A positive Δ(SNP-index) value indicates an increase in alleles from NHP1337. Red and blue lines show the 95% and 99% confidential intervals that match with the relevant window depth at each SNP. (C) Tricube-smoothed selection coefficients (s). Estimation of *s* was based on the changes of allele frequency from day25 to day50. The mean selection coefficient was adjusted to 0 to remove the influence of selfed progeny. Positive values of *s* indicate a disadvantage for alleles from NHP1337. Orange and black lines indicate experimental replicates.](pgen.1008453.g005){#pgen.1008453.g005}

Fine mapping of chr 12 and 14 QTLs {#sec009}
----------------------------------

We calculated 95% confidence intervals to narrow down the genes driving selection within the two QTL regions. The QTL on chr 12 ranged from 1,102,148 to 1,327,968 (226 kb) and the QTL on chr 14 ranged from 2,378,002 to 2,541,869 (164 kb).

[Chr 12]{.ul}: The QTL region contained 48 genes, with 27 genes bearing at least one non-synonymous mutation differentiating the two parents (**[Fig 6](#pgen.1008453.g006){ref-type="fig"} and [S2 Table](#pgen.1008453.s010){ref-type="supplementary-material"}**). Among the candidate genes with functional annotation, the multidrug resistance-associated protein 2 gene (*mrp2*, PF3D7_1229100) was located at the peak of the chr 12 QTL (**[Fig 6A](#pgen.1008453.g006){ref-type="fig"} and [S2 Table](#pgen.1008453.s010){ref-type="supplementary-material"}**). The *mrp2* allele from NHP1337 carries three indels (3--24 bp) within coding microsatellite sequences compared with that in MKK2835. These indels don't interrupt the open reading frame.

![**Overview of the genes inside the QTL regions on chr 12 (A) and chr 14 (B).** Black dashed vertical lines are boundaries of the 95% confidential intervals (CIs) of the QTL. The QTL on chr 12 spanned 226 kb and included 48 genes, and the QTL on ch14 spanned 164 kb and included 45 genes. 2D structure of MRP2 and ARPS10 are presented in boxes next to the G' plot. The structure of MRP2 was adapted from Velga et al., 2014. There are 5 microindels in the coding region of the Pfmrp2 gene (I-V, orange and green blocks). Four of the microindels (orange blocks, 1 SNP and 3 indels) are different between the ART-S and ART-R parental strains. The changes in peptide length relative to *P*. *falciparum* 3D7 are indicated next to the microindels, as microindel: ART-S/ART-R. ART-S and ART-R parasites have the same amino acid insertion at microindel I, but the sequence includes a synonymous mutation. The structure of ARPS10 was predicted by I-TASSER. ART-R has two non-synonymous mutations in *ARPS10*, Val127Met and Asp128His (red stars). TMD: transmembrane domain; NBD: nucleotide-binding domain; SP: signal peptides.](pgen.1008453.g006){#pgen.1008453.g006}

[Chr 14]{.ul}: There are 45 genes located in this QTL and 13 contained non-synonymous mutations that distinguish the two parents (**[Fig 6](#pgen.1008453.g006){ref-type="fig"} and [S2 Table](#pgen.1008453.s010){ref-type="supplementary-material"}**). The gene encoding apicoplast ribosomal protein S10 (*arps10*, PF3D7_1460900) was located at the peak of this QTL. There are two non-synonymous mutations (Val127Met and Asp128His) detected in *arps10* from NHP1337 as compared to MKK2835. The Val127Met mutation was suggested to provide a permissive genetic background for artemisinin resistance-associated mutations in *kelch13* in a genome-wide association analysis \[[@pgen.1008453.ref031]\].

Discussion {#sec010}
==========

Pervasive selection in a *Plasmodium* genetic cross {#sec011}
---------------------------------------------------

In this experiment, we observed both genome-wide selection against selfed progeny, and locus specific selection that resulted in skews in the frequency of particular parental alleles in progeny.

Genome-wide selection against selfed progeny {#sec012}
--------------------------------------------

Initially, frequencies of alleles derived from the two parental parasites were strongly skewed (0.81 ± 0.08) towards the NHP1337 parent. This deviation from the expected 0.5 ratio for outcrossed progeny occurs because hermaphroditic malaria parasites produce both male and female gametocytes; fusion between male and female gametes of the same genotype (selfing) is possible. The simplest explanation for this observed skew is that an excess of selfed progeny were generated from the NHP1337 parent genotype compared to the MKK2835 parent. We plotted the correlations between mitochondrial frequencies and frequencies of SNPs on different chromosomes across the experiment (**[S8 Fig](#pgen.1008453.s008){ref-type="supplementary-material"}**). Strong correlations show that alleles are not segregated independently, supporting selfing. We also cloned progeny collected on day 23 of the experiment, which confirmed our suspicion that selfing of NHP1337 lead to the skew in allele frequency (Button-Simmons et al. in preparation). Of 212 cloned genotyped progeny recovered, 144 (68%) were ART-R selfed, 5 (2%) were ART-S selfed, and 63 (30%) were recombinant progeny, representing 60 unique recombinants. Interestingly, our bulk sequencing data demonstrated an 86% frequency of alleles from the ART-R parent. In the cloned progeny, we observed 68% + (30%/2) = 83% extremely close to our estimation from bulk sequencing data. The data from the cloned progeny strongly reinforces our conclusions from the bulk data. It is currently unclear whether the excess selfed progeny from the NHP1337 parent relative to the MKK2835 parent resulted from an imbalance in gametocytes from these parental parasites when staging the cross, or from inherent differences in propensity to self in these two parasite clones.

Frequencies of the NHP1337 genome remained high from day 10 (mature oocysts) until day 30 (after 10 days of *in vitro* blood culture). At this point, genome-wide frequencies of the NHP1337 parasite declined significantly from 0.85 to 0.54 on day 42. We observed a parallel decline of both mitochondrial and autosomal allele frequencies for the NHP1337 parasite. This is consistent with selection removing selfed NHP1337 genotypes from the progeny, otherwise we would expect selection on these two genomes to be decoupled. Selection was extremely strong (mitochondrial *s* = 0.22 ±0.01; autosomal *s* = 0.24 ±0.02) for both genomes. Furthermore, we observed the same patterns using whole genome sequencing and amplicon sequencing for measuring allele frequencies of mtDNA (**[S2 Fig](#pgen.1008453.s002){ref-type="supplementary-material"}**), suggesting that our results are robust across methodological biases. Analysis of further crosses will allow us to determine whether selection against selfed progeny is a general feature of crosses in malaria parasites.

These data demonstrate systematic selection against genotypes generated by selfing of the ART-R parent. Reproduction by outcrossing is prevalent in nature, even in hermaphroditic species \[[@pgen.1008453.ref041]\]. Inbreeding leads to reduced fitness of offspring (inbreeding depression), while outbreeding among genetically differentiated individuals improves the performance of the F1 generation (heterosis) \[[@pgen.1008453.ref041], [@pgen.1008453.ref042]\]. We observed strong selection against selfed NHP1337 genotypes which resulted in elimination of selfed progeny in six asexual cycles (day 30--42). Possible explanations for the lower fitness of selfed progeny include: (1) recombination allows removal of deleterious mutations in outcrossed progeny. Accumulation of deleterious mutations occurs during clonal expansion and in inbred parasite lineages. Both parental parasites used in this cross were isolated from Southeast Asia, an area of low parasite transmission intensity, where most infected patients harbor a single parasite genotype. As a consequence mosquito blood meals contain male and female sexual stages from the sample parasite clone, and therefore deleterious mutations can accumulate since inbreeding predominates \[[@pgen.1008453.ref043], [@pgen.1008453.ref044]\]. We speculate that recombinant genotypes generated by outcrossing between the NHP1337 and MKK2835 parents reduced the numbers of deleterious alleles and therefore outcompeted inbred parental genotypes. (2) *In vitro* culture, where the strongest selection was observed in this experiment, represents an ecological niche change for both parental genotypes. Recombinants generated by outbreeding may be more fit in these laboratory conditions. (3) The selfed NHP1337 parasites that predominate initially are ART-R which may carry a fitness cost relative to ART-S parasites \[[@pgen.1008453.ref015], [@pgen.1008453.ref016], [@pgen.1008453.ref045]\]. We note that alleles at the two loci (chr 12 and 14) that are selected against (see [discussion](#sec010){ref-type="sec"} section "Locus Specific selection") during days 30--50 are both derived from the ART-R parent.

There is an interesting shift in allele frequencies between sporozoites sampled from mosquito salivary glands and liver stage parasites recovered from infected mice on day 21 (**[Fig 2](#pgen.1008453.g002){ref-type="fig"}**), with liver stage parasites carrying high frequencies of NHP1337 alleles (liver 0.89 vs sporozoites 0.79, with large Cohen's *d* effect size \[0.89\]). The allele frequency of parasites from *in vivo* blood collected on the same day is 0.84, which is between those from sporozoites and liver stage parasites. During liver stage development, single sporozoites take up residency within hepatocytes and divide mitotically over the course of \~7 days (determined with laboratory strains of *P*. *falciparum* NF54 \[[@pgen.1008453.ref046]\]) until liver schizonts burst releasing tens of thousands of merozoites into the blood. The simplest explanation of the observed allele frequency shift is a genotype-dependent variation in the duration of parasite liver stage development. We suggest that the selfed NHP1337 progeny remain in the liver longer and thus at the day 7 sampling, recombinant liver stage parasites have already transitioned to blood stage, generating the observed difference in allele frequencies. Further work is needed to directly determine the duration of liver stage development and if other liver stage parasite phenotypes (schizont size/merozoite numbers) differ among parasite genotypes.

Locus specific selection {#sec013}
------------------------

We observed a progressive increase in the variance of allele frequencies of SNPs from day 30--50 (during blood stage culture) (**[Fig 2A](#pgen.1008453.g002){ref-type="fig"}**). Several features of these data suggest that this is primarily driven by selection, rather than genetic drift. First, we noted an extremely strong repeatability in allele frequency skews across the genome in the two replicate parasite cultures established from the humanized mouse infection. This is reflected in the high correlation between allele frequencies between these two replicates at the end of the experiment (**[Fig 3](#pgen.1008453.g003){ref-type="fig"}**, day 50) when variance in allele frequency is at its maximum. The strong repeatability in patterns of skew observed suggest that there are multiple loci across the genome that influence parasite growth rate and competitive ability. Second, we see several regions of the genome that show extreme skew relative to the genome wide average. Two genome regions in particular (on chr 12 and on chr 14) show strong and significant skews that cannot be explained by drift. These allelic skews also increase progressively from 25--50 days, consistent with selection coefficients (*s*) of 0.18/48 hr asexual cycle for the chr 14 locus and (*s*) of 0.12/48 hr asexual generation for the chr 12 locus.

We observed strong selection against particular alleles segregating in this genetic cross (in the absence of drug pressure). How can such strongly disadvantageous alleles be maintained in natural parasite populations? We suggest three explanations. First, we think that the most likely explanation is that the fitness of these alleles may depend on genetic background \[[@pgen.1008453.ref047]\] and reflect epistatic interactions. We note that of the two parental strains used in this study, MKK2835 (ART-S) was isolated in 2003, while NHP1337 (ART-R), was collected in 2013. In the 10 years between 2003--13, artemisinin-resistant parasites spread to high frequency on the Thailand-Myanmar border \[[@pgen.1008453.ref025]\]. Intense drug selection in this 10-year interval has led to accumulation of additional genetic changes associated with ART-R, which may act epistatically with other ART-R-associated genes \[[@pgen.1008453.ref030]\]. It is certainly interesting that the chr 14 QTL contains *arps10*, which has been suggested to provide a permissive background for ART-R evolution \[[@pgen.1008453.ref031]\]. Outcrossing between individuals with different adaptations can result in disruption of this selective advantage, resulting in a loss of fitness \[[@pgen.1008453.ref048]\]. Further experimental work such as pairwise competition assays between recombinant progeny carrying different chr12 and chr14 haplotypes will be required to confirm the role of these loci, alone or in combination, in determining fitness. Second, there is a possibility that *de novo* deleterious mutations in these two QTL regions were fixed in the cloned NHP1337 parasites during the brief period of laboratory culture. We think this is unlikely because we also see pervasive selection at multiple genes outside these two major QTL regions, just with lower significance using G' statistics. The overall recombination rate in this cross was 13.8 kb/cM (Button-Simons et al. in preparation). We further counted the recombination events between chr 12 and 14 loci ([S5 Table](#pgen.1008453.s013){ref-type="supplementary-material"}). There were 35 recombination events observed in the 60 unique recombinant progeny between the chr 12 and 14 segments. The recombination between these two loci was even, which indicated that the detection of fitness traits at these two loci were independent. Third, we cannot discount the possibility that the strong selective disadvantages observed within these QTL regions reflects the artificial nature of this system with humanized mice and asexual culturing of parasites. During normal transmission in the field, selection against these genes may not be present.

We note that similar bulk segregrant experiments examining fitness determinants in *C*. *elegans* \[[@pgen.1008453.ref005]\] also detected QTLs with large effect sizes in several different genome regions. The QTL regions identified corresponded to the location of known selfish elements, or co-localized with major eQTLs, consistent with the idea that epistatic interactions are important in fitness related traits. Similarly, analysis of *C*. *elegans* recombinant inbred lines generated in a 16-parent genetic cross revealed that \~40% of the variance of a key fitness trait (fertility) resulted from epistatic interactions between loci \[[@pgen.1008453.ref049]\]. These *C*. *elegans* papers support the argument (above) that variation in fitness may be retained within natural populations due to epistasis among the genes involved.

We anticipate that intensity of competition among parasite clones within infected patients may closely parallel the patterns we observed within our genetic cross. The estimated occurrence rate of mixed infections ranges from 18% to 63% in African and Southeast Asia countries \[[@pgen.1008453.ref043], [@pgen.1008453.ref050]\]. Although there was likely more intense competition in this experimental cross, with millions of sporozoites infecting a single mouse, single cell sequencing has revealed seventeen unique clones in a single human infection \[[@pgen.1008453.ref051]\], which suggests that similar competitive interactions will also occur in patients. We note that while the intensity of competition may be similar in humanized mice, *in vitro* parasite cultures or infected humans, the nature of selection may differ. In infected people, parasite genotypes that allow evasion of immunity or alter parasite cytoadhesion properties may be selected, while growth competition is likely to be the predominant selective force in immunosuppressed humanized mice or *in vitro* culture.

What drives QTL peaks on chr12 & chr14? {#sec014}
---------------------------------------

Inspection of the genes under the QTL peaks allows us to speculate about the specific genes that may be driving the selection observed. Miotto et al. (2015) showed that four different non-*kelch13* loci (ferredoxin, *fd*; apicoplast ribosomal protein S10, *arps10*; multidrug resistance protein 2, *mdr2*; chloroquine resistance transporter, *crt*) are associated with the resistance phenotype, but not directly responsible for resistance. They suggested that a suite of background mutations was a prerequisite for mutations in *kelch13*. In our experiment, *arps10* falls near the peak of the strongly selected chr 14 locus (**[Fig 6](#pgen.1008453.g006){ref-type="fig"}**), which could suggest a functional relationship. We examined the presence of the background mutations found in both parental strains. The ART-R parent, NHP1337, contains mutations in all four of the genes described by Miotto et al. \[[@pgen.1008453.ref031]\] (*fd*, *mdr2*, *crt and arps10*), while the ART-S parent, MKK2835, contains three of these mutations (*fd*, *mdr2* and *crt*), thus only *arps10* mutations are segregating in this cross. It will be interesting to test the role of the remaining three loci (*fd*, *mdr2* and *crt*) by conducting additional experimental crosses.

The multidrug resistance-associated proteins (MRPs), belong to the C-family of ATP binding cassette (ABC) transport proteins that are well known for their role in multidrug resistance. Rodent malaria parasites encode one single MRP protein, whereas *P*. *falciparum* encodes two: MRP1 and MRP2 \[[@pgen.1008453.ref052]\]. Several studies have shown that PfMRP1 is associated with *P*. *falciparum's* response to multiple anti-malaria drugs and that disruption of PfMRP1 influences the fitness of parasites under normal culture conditions \[[@pgen.1008453.ref053]--[@pgen.1008453.ref055]\]. The function of PfMRP2 is not as well understood. Transfection studies have shown that MRP2-deficient malaria parasites are not able to maintain a successful liver stage infection \[[@pgen.1008453.ref052], [@pgen.1008453.ref056]\]. In our study, *mrp2* was found located at the peak QTL on chr12. We speculate that *mrp2* may also play a role in parasite fitness during asexual parasite stages. However, we cannot exclude that other neighboring loci may drive the observed allele frequency changes. To confirm the roles of individual genes inside the QTL regions (on both chr12 and chr14), gene-editing studies will be required.

We further analyzed the ancestral/derived allelic state of genes inside the QTL regions of chr 12 and chr14 ([S1 File](#pgen.1008453.s015){ref-type="supplementary-material"}, [S6 Table](#pgen.1008453.s014){ref-type="supplementary-material"}). For both *pfmrp2* and *pfarps10*, the selected alleles in the ART-S parent contained ancestral, rather than derived alleles. Deleterious derived alleles in the ART-R parasites may therefore explain the skews observed on chr12 and 14. We also analyzed the allele frequency distribution among Southeast Asia parasites. We used 678 single clone Southeast Asian parasite lines from the Sanger pf3k project (<ftp://ngs.sanger.ac.uk/production/pf3k/release5/>). For pf*mrp2*, the selection was against minor alleles, while for *pfarps10*, selection was against major alleles.

No selection against the *kelch13*-C580Y allele conferring ART resistance {#sec015}
-------------------------------------------------------------------------

Interestingly, we did not see evidence for selection against the *kelch13*-C580Y allele (chr 13) that underlies resistance to ART treatment. We previously used CRISPR/Cas9 editing to insert the C580Y substitution to a wild type parasite \[[@pgen.1008453.ref016]\]. Head-to-head competition experiments revealed strong fitness costs (*s* = 0.15/asexual cycle) associated with this substitution. In agreement, Straimer et al \[[@pgen.1008453.ref015]\] conducted similar experiments with Cambodian parasites: they showed that the addition of the C580Y mutation resulted in strong fitness costs for some parasites, but had no fitness impact in recently isolated Cambodian parasites. These data also suggest that epistatic interactions with other loci may compensate and restore parasite fitness. We suspect that this may also be the case in our experiment.

Technical considerations & caveats {#sec016}
----------------------------------

### Maximizing statistical power {#sec017}

Our statistical power to detect QTLs is limited by the number of recombinants generated. In our experiment, the mouse was infected with sporozoites from 204 mosquitoes carrying on average of three oocysts. Given that each oocyst is expected to contain sporozoites representing up to four different genotypes (i.e. a tetrad), the number of sporozoite genotypes is 204 × 3 × 4 = 2448 in this cross. We can increase the power of these experiments using mosquitoes with higher infection rates. We routinely obtain an average of 10 oocysts/mosquito, so can potentially increase numbers of recombinants by at least three-fold with the same number of mosquitoes. A second advantage of humanized mice over splenectomized chimpanzees as an infection model is that we can easily increase numbers of humanized mice used per cross. By using independent pools of mosquitoes to infect mice, we can multiply the numbers of recombinants generated, while also establishing true biological replicates of each experiment. A third advantage of the humanized mouse system is that we can stage independent crosses with different pairs of ART-R and ART-S parasites to determine if our conclusions are robust.

In this experiment, we found large numbers of inbred progeny generated by mating between male and female gametes of the same genotype. While we were able to use these to document selection against selfed progeny, this reduces the number of recombinant progeny and therefore limits statistical power for locating QTLs. For example, in our cross we estimated that 2448 sporozoite genotypes were initially used to infect the mouse. However, of these only 30% (estimated from dilution cloning of progeny) were recombinants, while the remaining 70% resulted from selfing (Button-Simmons et al. in preparation). Hence the number of independent recombinants used in this cross was no more than 2448 × 30% = 734. A method that maximizes outcrossing would be particularly useful for future crosses. For example, aphidicolin treatment has been successfully used in rodent malaria systems to kill male gametes \[[@pgen.1008453.ref057]\]. In yeast, BSA experiments use parental strains with different mating types to avoid inbreeding \[[@pgen.1008453.ref004]\]. We are not yet able to do this with malaria *P*. *falciparum* crosses. The dynamics observed in our cross with selection against selfed progeny followed by allele specific selection reflects important differences between *Plasmodium* and yeast systems.

We expect that representation of individual parasite clones will be uneven within progeny pools. Elevated growth of particular "high fitness" clones can generate step-like changes in allele frequency at the recombination points. This has the potential to generate spurious peaks and to confuse the interpretation of BSA experiments \[[@pgen.1008453.ref013], [@pgen.1008453.ref058]\]. To identify such abrupt allele frequency jumps, we performed a jump-diffusion analysis as described by Abkallo *et al* \[[@pgen.1008453.ref013]\]. This approach identified three allele frequency jump locations in the first experimental repeat of the day 50 population, while no allele frequency jumps were found in the second experimental repeat (**[S3 Table](#pgen.1008453.s011){ref-type="supplementary-material"} and [S5 Fig](#pgen.1008453.s005){ref-type="supplementary-material"}**). One of the three jumps is located at the left end of chr 12 QTL, which indicates the possibility of the chr 12 QTL being generated by clonal growth. However, we detected no allele frequency jumps in the vicinity of the chr 14 QTL.

### Combining BSA with cloning recombinant progeny to detect epistasis {#sec018}

BSA cannot be used to directly examine epistatic interactions, due to the lack of haplotype information. Fortunately, *P*. *falciparum* has a key advantage over rodent malaria systems because parasites can be grown *in vitro* and cloned by limiting dilution. Hence, BSA can be complemented by cloning progeny from the same genetic cross and directly examining haplotypes carrying different allele combinations. Furthermore, we can use BSA to directly test for interactions between genes. For example, we suspect that interactions between *kelch13* mutations and *arps10* may drive the skew observed at chr 14. This hypothesis can be directly tested by repeating the cross with parasites that have been edited to remove the *kelch13* mutation or candidate *arps10* mutations, to see if the skew on chr 14 disappears.

### sWGA performance {#sec019}

The sWGA method efficiently enriched *P*. *falciparum* DNA from infected mosquito and mouse tissues, confirming the performance of this approach for enriching parasite DNA from dried blood spots \[[@pgen.1008453.ref020]--[@pgen.1008453.ref023]\]. Our results further show that sWGA does not generate bias in allele frequency measurement (**[Fig 4](#pgen.1008453.g004){ref-type="fig"}**). However, sWGA does have limitations with highly contaminated samples, such as early infected mosquitoes (four days post infection). DNA extracted from day 4 midguts typically contains \> 99.99% mosquito DNA. Only 4.3% of sWGA products from these samples were *Plasmodium* DNA. In contrast, we were able to obtain \> 88% of parasite DNA from sWGA, with starting material containing ≥ 1% *P*. *falciparum* DNA (**[Table 1](#pgen.1008453.t001){ref-type="table"}**).

### Potential of BSA for examining selection in the mosquito stage {#sec020}

We did not observe allele frequency changes during mosquito infections in this experiment. We suggest two reasons for this. First, the *Anopheles stephensi* mosquito used is originally from urban India and widely spread across Southeast Asia, and therefore may show good compatibility with Southeast Asian parasites. Furthermore, this specific mosquito line has been long-term lab adapted, and is highly susceptible to infection with multiple parasite lines. Second, the infection period in mosquitoes in this experiment is relatively short, because we sacrificed all the mosquitos in two weeks. As a consequence, we can only detect very strong selection at this stage. However, hard selection resulting from incompatibility between parasites and mosquitoes should still be possible to detect and map in this system. We note that Molina-Cruz et al \[[@pgen.1008453.ref059]\] were able to determine parasite QTLs for compatibility between *P*. *falciparum* and mosquitoes using parasite progeny derived from the original malaria crosses conducted in chimpanzees, providing proof-of-principal that this is possible.

Human malaria can now undergo liver stage development within humanized mice, while blood stage parasites can be grown *in vitro* in culture and cloned. The power of the BSA approach has been clearly demonstrated in rodent malaria, where it has been used to identify the genetic components controlling a broad range of selectable phenotypes, including virulence and immunity, growth rate and drug resistance \[[@pgen.1008453.ref008]--[@pgen.1008453.ref012]\]. However, human malaria parasites and rodent malaria parasites are genetically distant and human parasites show numerous unique biological features not found in rodent malaria parasites. Our approach can now be applied to directly study multiple selectable traits in the human parasite *P*. *falciparum* via genetic crosses. We anticipate that BSA will provide a powerful approach for the study of *P*. *falciparum* genetics.

Material and methods {#sec021}
====================

Ethics approval and consent to participate {#sec022}
------------------------------------------

The study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH), USA. To this end, the Seattle Children's Research Institute (SCRI) has an Assurance from the Public Health Service (PHS) through the Office of Laboratory Animal Welfare (OLAW) for work approved by its Institutional Animal Care and Use Committee (IACUC). All of the work carried out in this study was specifically reviewed and approved by the SCRI IACUC.

Preparation of genetic cross and sample collection {#sec023}
--------------------------------------------------

We generated the cross using FRG NOD huHep mice \[[@pgen.1008453.ref060]\] with human chimeric livers and *A*. *stephensi* mosquitoes as described by Vaughan *et al*. \[[@pgen.1008453.ref018]\] (see [S1 File](#pgen.1008453.s015){ref-type="supplementary-material"} for details). We collected samples from infected mosquito midgut and salivary gland, mouse liver and *in vivo* blood, and *in vitro* blood cultures (**[Fig 1](#pgen.1008453.g001){ref-type="fig"} and [Table 1](#pgen.1008453.t001){ref-type="table"}**). We fed \~500 mosquitos with mixed gametocytes from each parent at equal ratio. This day was defined as day 0 for sample collecting. Forty-eight midguts were dissected at each oocyst collection time point (day 4 and day 10). The prevalence of infection was analyzed at day 10. Salivary gland were separated to collect sporozoites at day 14 after infection. Sporozoites from 204 mosquitoes were mixed together for infection into the mouse and for isolation of genomic DNA.

Six days after sporozoite injection (day 20), we injected mice intravenously with 400 μL of packed O+ huRBCs. The intravenous injection was repeated the next day (day 21). Four hours after the second huRBC injection, mice were sacrificed and blood was removed by cardiac puncture in order to recover *P*. *falciparum*--infected huRBCs. The mouse liver was dissected, immediately frozen in liquid nitrogen and then stored at −80°C.

The infected red blood cells were washed, mixed with equal volume of packed huRBCs, and resuspended in complete medium at 2% hematocrit. Two days after culture, the parasites were split equally into two wells (repeat A and repeat B) of a standard six-well plate. About 50 μL of freshly packed huRBCs were added every 2 days to each replicate. To maintain healthy cultures, serial dilutions of parasites were carried out once the parasitemia reached 4%. The cultures were maintained for 30 days in total (day21-day50), and 50ul packed red blood cells (RBCs) were collected and frozen down every 2--4 days. We also set up gametocyte enrichment cultures from day 32 progeny population with daily medium changes but no fresh huRBCs. Samples were collected 8 days (day 40) and 16 days (day 48) later.

Library preparation and sequencing {#sec024}
----------------------------------

We extracted and purified genomic DNA using the Qiagen DNA mini kit, and quantified amounts using Qubit. We performed real-time quantitative PCR (qPCR) reactions to estimate the proportion of parasite genomes in each DNA sample (**[S1 File](#pgen.1008453.s015){ref-type="supplementary-material"}**, **[S4 Table](#pgen.1008453.s012){ref-type="supplementary-material"}**). We used selective whole genome amplification (sWGA) to enrich parasite DNA for samples obtained from infected mosquito and mouse tissues. We used selective whole genome amplification (sWGA, **[S1 File](#pgen.1008453.s015){ref-type="supplementary-material"}**) to enrich parasite DNA for samples obtained from infected mosquito and mouse tissues. sWGA products were further quantified by qPCR (described above) to confirm that the majority of the products were from *Plasmodium*. We constructed next generation sequencing libraries using 50ng DNA or sWGA product following the KAPA HyperPlus Kit protocol with 3-cycle of PCR.

We used amplicon sequencing to trace the biases in mtDNA transmission, as sWGA with circular DNA may swamp out other sWGA products. We use at least 1000 copies of parasite genome as template for each reaction. Illumina adapters and index sequences were added to the PCR primers (**[S4 Table](#pgen.1008453.s012){ref-type="supplementary-material"}**). Equal number of molecules were pooled from each reaction.

All libraries were sequenced to an average coverage of 100x using an Illumina NEXTseq 500 sequencer.

Genotype calling {#sec025}
----------------

We first genotyped the two parental strains. We mapped the whole-genome sequencing reads against the *P*. *falciparum* 3D7 reference genome (PlasmoDB, release32) using BWA mem (<http://bio-bwa.sourceforge.net/>) under the default parameters. To reduce false positives due to alignment errors, we excluded the high variable genome regions (subtelomeric repeats, hypervariable regions and centromeres) and only performed genotype calling in the 21 Mb core genome (defined in \[[@pgen.1008453.ref034]\]). The resulting alignments were then converted to SAM format, sorted to BAM format, and deduplicated using picard tools v2.0.1 (<http://broadinstitute.github.io/picard/>). We used Genome Analysis Toolkit GATK v3.7 (<https://software.broadinstitute.org/gatk/>) to recalibrate the base quality score based on a set of verified known variants \[[@pgen.1008453.ref034]\].

We called variants for each parent using HaplotypeCaller and then merged using GenotypeGVCFs with default parameters except for sample ploidy 1. We applied filters to the original GATK genotypes using standard filter methods described by McDew-White et al \[[@pgen.1008453.ref061]\]. The recalibrated variant quality scores (VQSR) were calculated by comparing the raw variant distribution with the known and verified *Plasmodium* variant dataset. Loci with VQSR less than 1 were removed from further analysis.

We generated a "mock" genome using GATK *FastaAlternateReferenceMaker* from the genotype of parent NHP1337 (C580Y). The reads from bulk populations obtained at each stage of the lifecycle were mapped to this genome. Only loci with coverage \> 30x were used for bulk segregant analysis. We counted reads with genotypes of each parent and calculated allele frequencies at each variable locus. Allele frequencies of NHP1337 were plotted across the genome, and outliers were removed following Hampel's rule \[[@pgen.1008453.ref062]\] with a window size of 100 loci (**[Fig 3](#pgen.1008453.g003){ref-type="fig"}**).

Bulk segregant analysis {#sec026}
-----------------------

We performed the BSA analyses using the R package QTLseqr \[[@pgen.1008453.ref063]\]. We first defined extreme-QTLs by looking for regions with false discovery rate (FDR) \< 0.01 using the G' approach \[[@pgen.1008453.ref064]\]. We then calculated the Δ(SNP-index) to show the direction of the selection \[[@pgen.1008453.ref065]\]. Once a QTL was detected, we calculated and approximate 95% confidence interval using Li's method \[[@pgen.1008453.ref066]\] to localize causative genes.

We also measured the fitness cost at each mutation by fitting a linear model between the natural log of the allele ratio (freq\[allele1\]/freq\[allele2\]) against time (measured in 48hr parasite asexual cycles). The slope provides a measure of the selection coefficient (*s*) driving each mutation \[[@pgen.1008453.ref067]\]. The raw *s* values were tricube-smoothed with a window size of 100 kb to remove noise \[[@pgen.1008453.ref068], [@pgen.1008453.ref069]\]. A positive value of *s* indicates selection against alleles from the ART-R parent (NHP1337), while a negative value of s indicates selection for NHP1337 alleles.

Supporting information {#sec027}
======================

###### Number of SNPs between NHP1337 and MKK2835 in 100kb genome windows.

NHP1337 and MKK2835 differ from the core genome sequence of 3D7 (PlasmoDB, release32) by 13,762 and 13,710 SNPs, respectively.

(TIF)

###### 

Click here for additional data file.

###### 

Mitochondrial allele frequencies estimated by amplicon sequencing (red) and whole-genome sequencing (black).

(TIF)

###### 

Click here for additional data file.

###### Allele frequencies across the genome following gametocyte enrichment of progeny population.

The enrichment was initiated at day 32. We collected samples for sequencing 8 days (day 40) and 16 days (day 48) later. We compared allele frequencies between gametocyte enrichment cultures (marked as "Gametocyte") and normal *in vitro* cultures (marked as "Mixture") which contained both asexual and sexual parasites.

(TIF)

###### 

Click here for additional data file.

###### Bulk segregant analysis by Δ (SNP-index) and G' values.

\(A\) Mapping of loci involved in parasite fitness during malaria parasite life cycle with Δ (SNP-index). (B) *G*' values calculated during mosquito, mouse and early blood stages. *G*' values of day 32--50 samples were shown in [Fig 5](#pgen.1008453.g005){ref-type="fig"}. Day 21.1 was mouse liver and day 21.2 was *in vivo* blood.

(TIF)

###### 

Click here for additional data file.

###### Sudden changes in allele frequency identified using a jump-diffusion model.

Location of possible allele frequency jumps (see [S4 Table](#pgen.1008453.s012){ref-type="supplementary-material"} for details) detected are marked by vertical lines; Repeat A and B represent results from two parallel *in vitro* blood cultures; QTL regions located at chr 12 and 14 are marked in grey. The chr 12 QTL has an allele frequency jump detected in the day50 sample in one of the two replicates. No jumps we detected close to the chr 14 in either replicate in the temporal samples examined.

(TIF)

###### 

Click here for additional data file.

###### Concordance between allele frequencies estimated before and after sWGA.

(TIF)

###### 

Click here for additional data file.

###### PCA plot using 678 single clone infection samples from Southeast Asia.

The genotype data was obtained from Sanger pf3k project (<ftp://ngs.sanger.ac.uk/production/pf3k/release5/>). The parent parasites from the cross analyzed in this study fall into KH1 group as defined by Miotto et al \[[@pgen.1008453.ref035]\].

(TIF)

###### 

Click here for additional data file.

###### Plot of corrections between mitochondrial frequencies and frequencies of SNPs on different chromosomes across the experiment.

The strong correlations for different genome regions are consistent with selection against inbred parasites.

(TIF)

###### 

Click here for additional data file.

###### Summary of statistics from bulk segregant analyses.

(XLSX)

###### 

Click here for additional data file.

###### Genes inside of QTL regions.

(XLSX)

###### 

Click here for additional data file.

###### Sudden changes in allele frequency identified using a jump-diffusion model.

(XLSX)

###### 

Click here for additional data file.

###### Primers used in this study.

(XLSX)

###### 

Click here for additional data file.

###### Recombination events within the chromosome 12 and 14 QTL regions.

(XLSX)

###### 

Click here for additional data file.

###### Ancestral/derived allelic state analysis under chr12 and chr14 QTL regions.

(XLSX)

###### 

Click here for additional data file.

###### Supplemental methods and materials.

(DOCX)

###### 

Click here for additional data file.
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Dear Dr Anderson,

Thank you very much for submitting your Research Article entitled \'Genetic mapping of fitness determinants across the malaria parasite Plasmodium falciparum life cycle\' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review again a much-revised version. We cannot, of course, promise publication at that time.

Two very detailed reviews were obtained from experts in the field. Both provided favorable opinions about the paper and its potential impact on our understanding of the genetics of P. falciparum, including implications for resistance to artemisinin. They also expressed their enthusiasm for the methods that were employed by the authors and the potential power they provide for classical genetic analysis of all the life cycle stages. However, both reviewers requested significant modifications to the manuscript before it would be acceptable for publication. In particular, the reviewers requested that additional information be provided, including greater details regarding the number of progeny obtained, the frequency of recombination, etc. The requested additional information is described in detail in the reviews. Both reviewers also described the value of including information from analysis of individual progeny to provide validation of some of the conclusions. It seems from the current manuscript that this information has been collected and analyzed and that the authors plan to publish it in a separate manuscript. Incorporating some of these data into the current manuscript would address many of the concerns and criticisms expressed by the reviewers and increase the likelihood of acceptance.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to <plosgenetics@plos.org>.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our [Submission Checklist](http://journals.plos.org/plosgenetics/s/submit-now#loc-submission-checklist).

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our [guidelines](http://journals.plos.org/plosgenetics/s/submission-guidelines#loc-materials-and-methods).

Please be aware that our [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability) requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as \"data not shown\" or \"unpublished results\" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the [Preflight Analysis and Conversion Engine](http://pace.apexcovantage.com/) (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

PLOS has incorporated [Similarity Check](http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and \'Revise Submission\' in the \'Submissions Needing Revision\' folder.

\[LINK\]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Kirk W. Deitsch

Guest Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer\'s Responses to Questions

**Comments to the Authors:**

**Please note here if the review is uploaded as an attachment.**

Reviewer \#1: In this manuscript, Li, Kumar et al present their analysis of a Plasmodium falciparum genetic cross, achieved using a humanized mouse model pioneered by the senior author Dr. Vaughan (Vaughan et al 2015 Nature Methods). Using two Southeast Asian parasites, they implement a clever combination of whole-genome sequence analysis (WGS), augmented by selective whole genome amplification (sWGA) when necessary to overcome low yields, and complemented by amplicon sequencing, to track changes throughout the life cycle in the genomes of the resulting progeny. The authors provide good evidence that sWGA yields allele frequencies that after smoothing are highly concordant with WGS data.

Their core results are that the artemisinin-resistant (ART-R) parent NHP1337 had mostly selfed in the oocysts that form in the mosquito post mating between the parental gametes, and that later during blood stage development the ART-R parental sequences were selected against in favor of genomic sequences from the ART-sensitive parent MKK2835. Counter selection was most evident in two large segments on chromosomes 12 and 14.

This is an emerging and powerful technology in the field of malaria research and achieving this cross is an important achievement. The genetic methods described herein are also likely to be interesting and informative not only to malaria researchers but to a broad group of researchers studying genetic crosses and looking for methods to examine progeny using bulk segregant analysis (BSA).

The downsides of this work are that ultimately the authors do not provide any experimental evidence to validate candidate loci in these two chromosomes that they suspect might cause a fitness cost. Nor do they provide any information from analysis of independent recombinant progeny that would further support differences in fitness, measured as relative differences in growth rates. There is also no description of how many independent recombinant progeny they actually obtained, or any information on where and how frequently recombination events occurred.

The authors do mention that validation of these candidate genes is required and I think it is reasonable to not expect that for this report. For the progeny however, I do think it's reasonable to request that the authors provide more information about how many independent recombinant vs selfed progeny were actually obtained, whether this was done at different time points post blood stage culture initiation (on day 21), and at least some presentation of whether recombination events were detected within the chromosome 12 and 14 loci that could further inform mapping of fitness traits. They should also mention whether any fitness studies have been conducted with progeny, and what that shows to date. If those studies have not been performed, they should cite the caveat of not having that information.

Additional elements of my review are detailed below. Some of this is covered above.

The regions on chromosomes 12 and 14 under apparent selective pressure were large: 226 and 164 kb respectively. The chromosome 12 locus contains 48 genes, of which 27 had at least one non-synonymous mutation that distinguished the two parents. The authors highlight mrp2 as a potential cause of this selection. However, mrp2 showed three indels within microsatellite coding sequences and the authors provide no additional experimental evidence that these indels might be causal for any relative differences in fitness. The segment on chromosome 14 contains 45 genes. These include the apicoplast ribosomal protein S10 (arps10) gene that carries two amino acid substitutions in the ART-R parent, of which the Val127Met mutation had earlier been associated with genetic backgrounds on which mutant K13 emerged (Miotto et al 2015 Nature Genetics). No experimental data are presented herein to confirm any contribution of this gene to fitness, and it may well be a background effect as opposed to a causal effect on parasite fitness.

Fig 2: The authors need to provide more detail on what they are showing with their Ridgeline plots in panel A, as not all readers can be expected to know how these are constructed. How many SNPs across the genome did they use to calculate the allele frequencies? What is the spread? Is this a type of confidence interval averaged across all SNPs? Also, say a SNP from the ART-R parent was seen in one of 30 reads, then is that considered a real value or is there a threshold below which a SNP is removed because it might be a sequence artefact?

 Figure 3 clearly shows that the vast majority of the parasites tested throughout the life cycle post meiosis were selfed progeny of the ART-R parent. An increase in representation of the ART-sensitive MKK2835 genome was only apparent in blood stage parasites from about day 42 onwards (i.e. about day 21 of blood stage culture). The figure clearly the dip in chromosomes 12 and 14, presumably reflecting the selective advantage of one or more loci in each segment. One result that is critically missing is how many progeny did they ultimately recover? Did they initiate cloning at different times including late? What were the numbers of independent vs. selfed progeny over time? Were recombination events observed in the chromosome 12 and 14 segments that could help further refine loci that segregate with fitness? Were fitness assays ever conducted with any independent recombinant progeny? If they only cloned early, what were the numbers of recovered selfed vs independent recombinant progeny?

Figure 4: The authors should detail in the legend on which day they performed their comparison. Presumably it was in late blood stage cultures.

Lines 149-50: "fuse to form a zygotes that then rapidly transforms into a short-lived tetraploid ookinetes" -- should be "zygote" and "ookinete"

Line 158: The estimate of 2448 recombinants assumes that all sporozoites were the result of outbreeding. That should be clarified as the authors show that substantial selfing (inbreeding) occurred amongst the progeny.

Line 191: The authors state that they used 3 h of amplification, which is explained in the supplemental file. That file lists only conditions of 35-30°C with Phi29 polymerase. I am not familiar with sWGA. Is that the only condition (other than the later 65°C to inactivate the enzymes), with no denaturation/extension steps? It would be helpful to have that method described in more detail in the supplement.

Line 234: When stating day 23, please specify that this corresponds to day 2 of in vitro blood stage culture, to avoid confusion.

S1 Fig shows a fairly small number of SNPs that differ between the parents. It would be helpful to compare each against the reference 3D7 genome, which I assume would show much greater differences. Also, researchers at the Sanger Institute and colleagues have over the years published a number of descriptions of population subgroups in Southeast Asia (e.g. the KH1-6 subgroups, or more recently the KEL subgroups). Can the authors provide more information on the subgroup affiliations of their parents? Would they consider these to be closely related? One informative way to do this would be to show a PCA plot with these two parents compared to other sequenced Southeast Asian genomes, if possible.

Reviewer \#2: General comments:

Excellent research. The work clearly required high technical laboratory skill to conduct. Analysis was sound and thourough. The inclusion of both mosquito and mouse stages has picked up some interesting changes in the parental/F1 populations that would not have been observed with fewer developmental stages. The lack of bias in the sWGA is convincing. I find it partcularly interesting that the kelch allele does not appear deleterious in these genetic backrounds. There is mch that is not explained, but in general most explanations would require further BSA\'s and/or gene manipulation, which I don\'t think are essential. I do suggest some extra analysis, as below.

Specific comments/issues:

1\. The discussion suggested that it was a surpise to see alleles under string selection, given that the alleles come from clinical isolates. I am not suprised by this, as similar BSA experiments in Drosophila, both yeast models and C. elegans show similar large effects sizes. My suspicion is that this is the result of a large panmictic popultation with a simple elction pressure (eg: P14,L374)

2\. The strong skew to he ART-R parent in mosquitio stage is unexpected. Any ideas why this occurs? Would you expect this to occur with another ART-R parent, for example?

3\. Selection of inbred progeny does seem to be evident (eg: Fig 2C). Ideally, I would like to see some proof within this manuscript. The ultimate would be cloning and some genotyping of clones. Fig2C could be improved: as the mito genome is only one haplotype, ou could easily correlate allele freq between two regions of one chromosome, or between chromosomes. Strong correlations would show that alleles were not segregating independently, hence supporting the selfing.

4\. Why do we see non segregating bias in Fig3 up to day 32, and then segregating allele freq changes after that? WHat do the outcrossed segregants appearing so late (this is not what people observe in yeast BSA experiments). Were selfed progeny lost?

5\. Selelection for different alleles or haplotypes could be towards new (derived) alleles or biased for ancestral alleles. Some analysis of alleles/haplotypes WRT allele frequencies in SE Asia and ancestral/derived state might reveal some interesting patterns. This could improve the implications of your BSA considerably.

6\. Data availablity. Submitting raw sequence data to SRA is the mimimum requirement. But you can easily do more, which will help other researchers and make re-use of you data more common. I find this increases citations and draws in new collaborators. I suggest making ALL processed data files available (in Figshare for example). This could include: VCF files of variants, data use to generate plots, read counts for alelles, and code used for selection.

Small errors/suggestions:

Page 2, line 39-43: Up and downwards skews could be explained more clearly.

P6,L152: reference for \~10,000 sporozoites

I suggest you clarify at very early in the text that this is only one cycle, not multiple mosquito/mouse/mosquito/mouse/ etc.

P7,L179, and in all other places in the ms, including Table 1: Your measures are unlikely to be accurate to TWO decimal places. Please simplify. eg: 3%, 3% and 30% would be more readable and represent your data better.

P9,L243: What type of test used?

P11,L298: sense in \"we also dilution cloned progeny\"

P18,L459. Different ART-R and ART-S parents would also improve future studies.

PS: I am in favour of embedding figure legends, figures and tables within the text (rather than at the end) when sumitting manuscripts to journals. Placing them at the end makes reviewing moe diffcult, particularly on trains and flights \... Journals never have a problem with embedded figure in my experience.

\*\*\*\*\*\*\*\*\*\*

**Have all data underlying the figures and results presented in the manuscript been provided?**

Large-scale datasets should be made available via a public repository as described in the *PLOS Genetics* [data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: None

Reviewer \#2: No: While raw sequence data are available, I am in favour of processed data (VCF files etc) being made available.

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Daniel Jeffares
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Reviewer\'s Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer \#1: I commend the authors on a well-constructed rebuttal and revised manuscript. My key concerns as Reviewer 1 have now been satisfactorily addressed. My comments below are minor and can be handled editorially. This is an excellent report that will be well appreciated and that raises interesting findings for follow up investigation.

The authors should specify in their Discussion that further work will be required to assess fitness-specific differences between recombinant progeny in order to confirm roles associated with chromosomes 12 and/or 14. Also they should state that future gene-editing studies will be simportant to confirm the role of individual genes in one or both chromosomal segments (on chromosomes 12 and/or 14). These could be woven into the Discussion, for example on lines 517 and 574.

Table S5: please define what is meant by "mix". Does this mean several different recombinant break points within those sets of progeny? Also, please list the boundaries of the two chromosomal regions in the footnote and the total length of each chromosome to make this more easily interpretable for readers.

In the revised abstract, there is no need to refer twice to P. falciparum as a human malaria parasite.

Reviewer \#2: Thank you for addressing all my concerns.

\*\*\*\*\*\*\*\*\*\*

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the

PLOS Genetics

[data availability policy](http://journals.plos.org/plosgenetics/s/data-availability), and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer \#1: Yes

Reviewer \#2: Yes
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PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosgenetics/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?

For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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